Back
Norfolk Southern Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
44
NSC
Norfolk Southern
Last Price:
$233.34
Seasonality Move:
4.6%
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
$73.40
Seasonality Move:
14.66%
Sell
44
Norfolk Southern (NSC)
is a Sell
Is Norfolk Southern a Buy, Sell or Hold?
-
The current Norfolk Southern [NSC] share price is $233.54. The Score for NSC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
NSC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $73.45. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NSC Stock Price Chart
What is Norfolk Southern's stock price today?
-
The Norfolk Southern share price today is $233.54Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NSC is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $73.45Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
NSC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.33 | Sell |
Relative Strength Index (14 RSI): | 39.75 | Sell |
Chaikin Money Flow: | -10726 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (233.77 - 251.59) | Sell |
Bollinger Bands (100): | (237.83 - 263.01) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.88 | Sell |
Relative Strength Index (14 RSI): | 27.08 | Sell |
Chaikin Money Flow: | -3203836 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (91.16 - 111.44) | Sell |
Bollinger Bands (100): | (104.49 - 127.75) | Sell |
NSC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 232.63 | Buy |
20-day SMA: | 239.25 | Sell |
50-day SMA: | 245.27 | Sell |
200-day SMA: | 243.62 | Sell |
8-day EMA: | 234.5 | Sell |
20-day EMA: | 238.67 | Sell |
50-day EMA: | 243.8 | Sell |
200-day EMA: | 244.43 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 90.54 | Sell |
20-day SMA: | 99.52 | Sell |
50-day SMA: | 109.68 | Sell |
200-day SMA: | 125.38 | Sell |
8-day EMA: | 87.58 | Sell |
20-day EMA: | 96.91 | Sell |
50-day EMA: | 106.43 | Sell |
200-day EMA: | 118.83 | Sell |
Norfolk Southern Earnings Growth & NSC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.59 per share, a decrease next quarter of $0.12 per share, an increase this year of $1.27 per share, and an increase next year of $1.84 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
Norfolk Southern Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |